UK pharma probes relationships with academia following UK parliamentary inquiry
The UK's pharma trade body on Thursday said it is investigating how the industry interacts with academia following a parliamentary inquiry into business-university collaboration.
The Association of the British Pharmaceutical Industry (ABPI) said in a statement it has submitted a written response to the inquiry, which finished gathering evidence on Wednesday.
In its statement the ABPI highlighted the importance of technology transfer from universities to industry, as well as pharma's role in developing and training PhD students.
ABPI head of education Sarah Jones, said: "The ABPI is carrying out a further survey of our members to assess the level of undergraduate placements, sponsorship of PhDs, and postdoctoral collaborations by pharmaceutical companies in the current academic year. This data will be published later this year."
The ABPI said it will publish its full written response to the Business, Innovation and Skills committee inquiry on its website "in due course".